Nuclear Medicine Group's research on coronary restenosis

  Life Sciences Division's Dr. Russ Knapp and the Nuclear Medicine Group are currently involved in research concerning prevention of restenosis following coronary angioplasty. In many cases, plaque will reform on arterial walls (restenosis) following "balloon" therapy (angioplasty) to open clogged arteries. Dr. Knapp has developed a procedure to prevent the restenosis which involves using a beta-emitter to fill the "balloon" during therapy. Research and development of this technique is being conducted in conjunction with the Nuclear Medicine Group's national and international collaboratives.

Contact: Russ Knapp
Phone: 574-6225
E-mail: jkp@ornl.gov